Sowell Financial Services LLC Biomarin Pharmaceutical Inc Transaction History

Sowell Financial Services LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 05, 2021	SELL	$75.51 - $84.79 $36,773 - $41,292	-487 Closed	0 $0
Q1 2021 May 07, 2021	BUY	$74.73 - $90.69 $5,156 - $6,257	69 Added 16.51%	487 $38,000
Q4 2020 Jan 13, 2021	BUY	$72.61 - $90.2 $8,858 - $11,004	122 Added 41.22%	418 $37,000
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $1,940 - $3,537	-27 Reduced 8.36%	296 $23,000
Q2 2020 Aug 13, 2020	SELL	$79.55 - $124.22 $715 - $1,117	-9 Reduced 2.71%	323 $40,000
Q1 2020 May 12, 2020	BUY	$71.37 - $96.85 $6,351 - $8,619	89 Added 36.63%	332 $28,000
Q4 2019 Feb 07, 2020	SELL	$64.27 - $86.37 $3,084 - $4,145	-48 Reduced 16.49%	243 $20,000
Q3 2019 Nov 14, 2019	BUY	$67.4 - $85.11 $19,613 - $24,767	291 New	291 $20,000

632

185M

1.63M

1.2M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $13.1B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Sowell Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Sowell Financial Services LLC with notifications on news.